Skip to main content

Advertisement

SpringerLink
Log in

An Update on Masked Hypertension

  • Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Masked hypertension refers to the phenomenon of having a non-elevated clinic blood pressure (BP) despite having an elevated out-of-clinic BP. Masked hypertension is a common phenotype with a cardiovascular risk profile similar to that of sustained hypertension, defined as elevated clinic and out-of-clinic BP. Current guidelines offer little guidance on the best practices for detecting and treating masked hypertension. This is in part due to insufficient evidence upon which to base recommendations as many questions remain regarding the optimal clinical management of masked hypertension. In this review, we will discuss the recent literature on masked hypertension related to disease prevalence, diagnosis, screening strategies, adverse outcomes, and treatment, and will highlight critical areas for future research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259(2):225–8.

    Article  CAS  PubMed  Google Scholar 

  2. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193–8.

    Article  CAS  PubMed  Google Scholar 

  3. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens. 2006;19(3):243–50.

    Article  PubMed  Google Scholar 

  4. Pierdomenico SD, Lapenna D, Di Mascio R, Cuccurullo F. Short- and long-term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens. 2008;22(6):408–14.

    Article  CAS  PubMed  Google Scholar 

  5. • Asayama K, Thijs L, Li Y, Gu YM, Hara A, Liu YP, et al. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension. 2014;64(5):935–42. This study reports the prevalence of and the risk of adverse events associated with masked hypertension when different time periods were used to identify masked hypertension on ambulatory blood pressure monitoring

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40(6):795–6.

    Article  CAS  PubMed  Google Scholar 

  7. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68.

    Article  PubMed  Google Scholar 

  8. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24(1):52–8.

    Article  PubMed  Google Scholar 

  9. Franklin SS, O'Brien E, Thijs L, Asayama K, Staessen JA. Masked hypertension: a phenomenon of measurement. Hypertension. 2015;65(1):16–20.

    Article  CAS  PubMed  Google Scholar 

  10. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.

    Article  PubMed  Google Scholar 

  11. Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada’s 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017;33(5):557–76.

    Article  PubMed  Google Scholar 

  12. (UK) NCGC. Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34. National Institute for Health and Clinical Excellence: Guidance. London: Royal College of Physicians; 2011.

    Google Scholar 

  13. Peacock J, Diaz KM, Viera AJ, Schwartz JE, Shimbo D. Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens. 2014;28(9):521–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens. 2008;26(9):1715–25.

    Article  CAS  PubMed  Google Scholar 

  15. • Melgarejo JD, Maestre GE, Thijs L, Asayama K, Boggia J, Casiglia E, et al. Prevalence, treatment, and control rates of conventional and ambulatory hypertension across 10 populations in 3 continents. Hypertension. 2017;70(1):50–8. This study demonstrates in a large, international cohort how masked hypertension prevalence varies across the world

    Article  CAS  PubMed  Google Scholar 

  16. Omboni S, Aristizabal D, De La Sierra A, Dolan E, Head G, Kahan T, et al. Hypertension types defined by clinic and ambulatory blood pressure in14143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016;34(11):2187–98.

    Article  CAS  PubMed  Google Scholar 

  17. • Wang YC, Shimbo D, Muntner P, Moran AE, Krakoff LR, Schwartz JE. Prevalence of masked hypertension among US adults with nonelevated clinic blood pressure. Am J Epidemiol. 2017;185(3):194–202. This study provides an estimate of what the prevalence of masked hypertension may be in a multi-ethnic US cohort

    PubMed  Google Scholar 

  18. Franklin SS, Thijs L, Li Y, Hansen TW, Boggia J, Liu Y, et al. Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension. 2013;61(5):964–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. • Redmond N, Booth JN, 3rd, Tanner RM, Diaz KM, Abdalla M, Sims M, et al. Prevalence of Masked Hypertension and Its Association With Subclinical Cardiovascular Disease in African Americans: Results From the Jackson Heart Study. Journal of the American Heart Association. 2016;5(3):e002284. This study examined the prevalence of masked hypertension and its association with subclinical cardiovascular disease among African Americans, a group with high rates of cardiovascular disease and both clinic and out-of-clinic hypertension.

  20. • Booth JN 3rd, Diaz KM, Seals SR, Sims M, Ravenell J, Muntner P, et al. Masked hypertension and cardiovascular disease events in a prospective cohort of blacks: the Jackson Heart Study. Hypertension. 2016;68(2):501–10. This study examined the risk of cardiovascular disease events among African Americans when masked hypertension was defined using different time periods (i.e. daytime, 24-hour, nighttime period)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Gaborieau V, Delarche N, Gosse P. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage. J Hypertens. 2008;26(10):1919–27.

    Article  CAS  PubMed  Google Scholar 

  22. Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30(7):1289–99.

    Article  CAS  PubMed  Google Scholar 

  23. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2008;26(7):1290–9.

    Article  CAS  PubMed  Google Scholar 

  24. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370(9594):1219–29.

    Article  PubMed  Google Scholar 

  25. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51(1):55–61.

    Article  CAS  PubMed  Google Scholar 

  26. •• Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163(9):691–700. This review examines ambulatory blood pressure monitoring and home blood pressure monitoring procedures, examines their use in clinical practice, and addresses relevant controversies associated with both modalities

    Article  PubMed  PubMed Central  Google Scholar 

  27. • Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hyperten : JASH. 2016;10(3):224–34.e17. This systematic review evaluated available evidence for both ambulatory blood pressure monitoring and home blood pressure monitoring in order to determine if either was superior for predicting cardiovascular disease events

    Article  Google Scholar 

  28. Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens. 2005;18(6):772–8.

    Article  PubMed  Google Scholar 

  29. • Viera AJ, Lin FC, Tuttle LA, Olsson E, Stankevitz K, Girdler SS, et al. Reproducibility of masked hypertension among adults 30 years or older. Blood Press Monit. 2014;19(4):208–15. This study examined the agreement between ambulatory blood pressure monitoring and home blood pressure monitoring in diagnosing masked hypertension

    Article  PubMed  PubMed Central  Google Scholar 

  30. Myers MG. A short history of automated office blood pressure—15 years to SPRINT. J Clin Hypertens (Greenwich). 2016;18(8):721–4.

    Article  Google Scholar 

  31. Beckett L, Godwin M. The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2005;5(1):18.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Grant FC, et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. BMJ. 2011;342:d286.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009;27(2):280–6.

    Article  CAS  PubMed  Google Scholar 

  34. • Wohlfahrt P, Cífková R, Movsisyan N, Kunzová S, Lešovský J, Homolka M, et al. Threshold for diagnosing hypertension by automated office blood pressure using random sample population data. J Hypertens. 2016;34(11):2180–6. This study sought to identify an appropriate threshold for diagnosing clinic hypertension when using automated office blood pressure devices

    Article  CAS  PubMed  Google Scholar 

  35. Siu AL. Force USPST. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778–86.

    Article  PubMed  Google Scholar 

  36. Anstey DE, Shimbo D. Masked hypertension-what lies ahead? J Hum Hypertens. 2017;31(9):545–6.

    Article  CAS  PubMed  Google Scholar 

  37. Booth JN 3rd, Muntner P, Diaz KM, Viera AJ, Bello NA, Schwartz JE, et al. Evaluation of criteria to detect masked hypertension. J clin hyperten (Greenwich, Conn). 2016;18(11):1086–94.

    Article  Google Scholar 

  38. • Viera AJ, Lin FC, Tuttle LA, Shimbo D, Diaz KM, Olsson E, et al. Levels of office blood pressure and their operating characteristics for detecting masked hypertension based on ambulatory blood pressure monitoring. Am J Hypertens. 2015;28(1):42–9. This study sought to identify a clinic blood pressure threshold above which masked hypertension may be more likely and when individuals should be referred for ambulatory blood pressure monitoring

    Article  PubMed  Google Scholar 

  39. Colantonio LD, Anstey DE, Carson AP, Ogedegbe G, Abdalla M, Sims M, et al. Metabolic syndrome and masked hypertension among African Americans: The Jackson Heart Study. Journal of clinical hypertension (Greenwich, Conn). 2017;19(6):592-600.

  40. Sheppard JP, Fletcher B, Gill P, Martin U, Roberts N, McManus RJ. Predictors of the home-clinic blood pressure difference: a systematic review and meta-analysis. Am J Hypertens. 2016;29(5):614–25.

    Article  PubMed  Google Scholar 

  41. Hanninen MR, Niiranen TJ, Puukka PJ, Jula AM. Metabolic risk factors and masked hypertension in the general population: the Finn-Home study. J Hum Hypertens. 2014;28(7):421–6.

    Article  PubMed  Google Scholar 

  42. • Anstey DE, Booth JN, 3rd, Abdalla M, Spruill TM, Min YI, Muntner P, et al. Predicted Atherosclerotic Cardiovascular Disease Risk and Masked Hypertension Among Blacks in the Jackson Heart Study. Circ Cardiovasc Qual Outcomes. 2017;e003421. This study investigated if higher 10-year predicted cardiovascular disease risk, using the pooled cohort risk equations, was associated with an increased prevalence of masked hypertension.

  43. Drawz PE, Alper AB, Anderson AH, Brecklin CS, Charleston J, Chen J, et al. Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016;11(4):642–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. • Hanninen MR, Niiranen TJ, Puukka PJ, Kesaniemi YA, Kahonen M, Jula AM. Target organ damage and masked hypertension in the general population: the Finn-Home study. J Hypertens. 2013;31(6):1136–43. This study examined the association of target organ damage and masked hypertension when home blood pressure monitoring is used to identify out-of-clinic hypertension

    Article  PubMed  Google Scholar 

  45. • Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol. 2015;66(20):2159–69. This study examined the association of masked hypertension with cardiovascular disease events in a large, multi-ethnic cohort

    Article  PubMed  PubMed Central  Google Scholar 

  46. •• Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G. Untreated masked hypertension and subclinical cardiac damage: a systematic review and meta-analysis. Am J Hypertens. 2015;28(6):806–13. This systematic review and meta-analysis identified the association of masked hypertension to subclinical cardiac damage and compared this risk to individuals with normal clinic and out-of-clinic blood pressure

    Article  PubMed  Google Scholar 

  47. •• Cuspidi C, Sala C, Tadic M, Rescaldani M, De Giorgi GA, Grassi G, et al. Untreated masked hypertension and carotid atherosclerosis: a meta-analysis. Blood Press. 2015;24(2):65–71. This systematic review and meta-analysis identified the association of masked hypertension to carotid intima-media thickness – a presumed measure of early carotid atherosclerosis – and compared this risk to individuals with normal clinic and out-of-clinic blood pressure

    Article  PubMed  Google Scholar 

  48. • Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. Prognosis of white-coat and masked hypertension: international database of home blood pressure in relation to cardiovascular outcome. Hypertension. 2014;63(4):675–82. Using a large international database, this manuscript provided evidence that masked hypertension identified using home blood pressure monitoring is associated with increased cardiovascular disease risk

    Article  CAS  PubMed  Google Scholar 

  49. •• Satoh M, Asayama K, Kikuya M, Inoue R, Metoki H, Hosaka M, et al. Long-term stroke risk due to partial white-coat or masked hypertension based on home and ambulatory blood pressure measurements: the Ohasama study. Hypertension. 2016;67(1):48–55. This study found that masked hypertension was associated with an increased risk of stroke compared to sustained normotension when masked hypertension was diagnosed only on ambulatory blood pressure monitoring but not on home blood pressure monitoring; and when diagnosed on home blood pressure monitoring but not ambulatory blood pressure monitoring

    Article  CAS  PubMed  Google Scholar 

  50. • Bromfield SG, Shimbo D, Booth JN, 3rd, Correa A, Ogedegbe G, Carson AP, et al. Cardiovascular Risk Factors and Masked Hypertension: The Jackson Heart Study. Hypertension. 2016;68(6):1475-82. This study found that lifestyle factors affect masked hypertension prevalence, and therefore lifestyle changes may be a potential treatment for masked hypertension.

  51. Tajeu GS, Booth JN, 3rd, Colantonio LD, Gottesman RF, Howard G, Lackland DT, et al. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg. Circulation. 2017;136(9):798-812.

Download references

Funding

This work was supported by P01-HL047540 and K24-HL125704 from the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH), and 15SFRN2390002 from the American Heart Association. DEA receives support through 2T32HL007854-21. MA and NAB are supported by UL1TR001873 and KL2TR001874 from the National Center for Advancing Translational Sciences, NIH.

Author information

Authors and Affiliations

  1. Columbia University Medical Center, 622 West 168th Street, PH 9-310, New York, NY, 10032, USA

    D. Edmund Anstey, Daniel Pugliese, Marwah Abdalla, Natalie A. Bello, Raymond Givens & Daichi Shimbo

Authors
  1. D. Edmund Anstey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Pugliese
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marwah Abdalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Natalie A. Bello
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Raymond Givens
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daichi Shimbo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Edmund Anstey.

Ethics declarations

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Blood Pressure Monitoring and Management

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anstey, D.E., Pugliese, D., Abdalla, M. et al. An Update on Masked Hypertension. Curr Hypertens Rep 19, 94 (2017). https://doi.org/10.1007/s11906-017-0792-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-017-0792-4

Keywords

Search

Navigation